Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9

Molecular Therapy

Volumn 3, Issue 1, 2001, Pages 54-60

  Ziske, Carsten ^a   Märten, Angela ^a   Schöttker, Björn ^a   Buttgereit, Peter ^a   Schakowski, Frank ^a   Gorschlüter, Markus ^a   Von Rücker, Alexander ^a   Scheffold, Christian ^b   Chao, Nelson ^c   Sauerbruch, Tilman ^a   Schmidt Wolf, Ingo G H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Dendritic cells; Immunotherapy; NK cells; Pancreatic neoplasm; RNA

Indexed keywords

CA 19-9 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; LIPOSOME; POLYADENYLATED RNA; RIBONUCLEASE; TUMOR ANTIGEN; TUMOR VACCINE;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CANCER RESISTANCE; CARCINOMA CELL; CELL TRANSFER; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; EFFECTOR CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PANCREAS CARCINOMA; PANCREAS TUMOR; PULSATILE DRUG RELEASE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; TUMOR CELL LINE; TUMOR IMMUNITY;

EID: 0034990302     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0230     Document Type: Article

References (31)

1. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms
2. Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein
3. Dendritic cells and the control of immunity
4. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
5. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA
6. Characterization of a messenger RNA polynucleotide vaccine vector
7. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization
8. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
9. RNA melanoma vaccine: Induction of antitumor immunity by human glycoprotein 100 mRNA immunization
10. Phenotypic characterization and identification of effector cells involved in tumor recognition of cytokine induced killer cells
11. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity
12. Propagation of T cells with NK cell marker
13. Increase of proliferation rate and enhancement of antitumor cytotoxicity of human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene
14. Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia
15. Activated T cells and cytokine-induced CD3+CD56+ killer cells
16. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype
17. The relationship of CD16(Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
18. Comparative studies of CD3- and CD3+ CD56+ cells: Examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression
19. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
20. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis: Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer
21. Propagation of large number of T cells with natural killer cell markers
22. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway
23. Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells
24. Expression of tumor-associated carbohydrate antigens correlates with hepatic metastasis of pancreatic cancer: Clinical and experimental studies on human pancreatic cancer-associated antigens detected by murine monoclonal antibodies
25. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity
26. An enzyme-release assay for natural cytotoxicity
27. Lineage relationships and differentiation of natural killer (NK) T cells: Intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules
28. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
29. Dendritic cells as adjuvants for immune-mediated resistance to tumors
30. Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients
31. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo